Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

The Emergence of the Designer Stimulants Fluorexetamine and 2-fluoro-2oxo-PCE in Clinical Urine Specimens

SOFT 2025

Society for Forensic Toxicologists

Portland, OR, Oct 26-31, 2025

Oral presentation: The Emergence of the Designer Stimulants Fluorexetamine and 2-fluoro-2oxo-PCE in Clinical Urine Specimens

Authors: Jillian R AA, Smith MP, Bartock SH

Medical Specialty: Prescription Drug Monitoring, Toxicology

Related content

Audio Podcast
Novel Psychoactive Substances (NPS): A Dangerous, Widespread Public Health Issue
Test FAQ
Novel Psychoactive Substances (NPS) Panel
On-Demand Webinar
The Growing Crisis of Novel Psychoactive Substances
Conference Presentation
Novel Psychoactive Substances (NPS) Prevalence in Clinical Urine Specimens at Quest Diagnostics in 2024
Conference Presentation
Novel Psychoactive Substance Presence in Fentanyl/Norfentanyl Positive Clinical Urine Specimens
Conference Presentation
Novel Psychoactive Substance Presence in Urine Specimens from a Large United States Prison System
Publication
Workplace Mental Health: Application of a Population Health Approach of Proactive Screening to Identify Risk and Engage in Care
Test FAQ
Drug Monitoring Antidepressants With Confirmation Urine and Serum
Conference Presentation
Should I test for Xylazine and other Novel Psychoactive Substances (NPS)? NPS Prevalence in Clinical Urine Specimens

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.